open access

Vol 68, No 3 (2017)
Review paper
Submitted: 2016-07-27
Accepted: 2016-11-10
Published online: 2017-06-21
Get Citation

Insulin resistance in endocrine disorders — treatment options

Anita Rogowicz-Frontczak1, Anna Majchrzak, Dorota Zozulińska-Ziółkiewicz
DOI: 10.5603/EP.2017.0026
·
Pubmed: 28660991
·
Endokrynol Pol 2017;68(3):334-351.
Affiliations
  1. Department of Internal Medicine and Diabetology, Poznan University of Medical Science, Poland

open access

Vol 68, No 3 (2017)
Review Article
Submitted: 2016-07-27
Accepted: 2016-11-10
Published online: 2017-06-21

Abstract

Changes in sensitivity to insulin occur in the course of a number of endocrine disorders. Most of the hormones through their antagonistic action to insulin lead to increased hepatic glucose output and its decreased utilisation in peripheral tissues. Carbohydrate disorders observed in endocrine diseases result from the phenomenon of insulin resistance, and in some cases also a reduction in insulin secretion is present. Abnormalities of glucose metabolism are observed in acromegaly, but also in growth hormone deficiency, hypercortisolism in the course of Cushing’s syndrome, hyper- or hypothyroidism, primary hyperparathyroidism, aldosteronism, pheochromocytoma, congenital hypertrophy of the adrenal glands, polycystic ovaries syndrome, hypogonadism, or other hormonally active neuroendocrine tumours. They are of a secondary nature in relation to impaired hormonal balance. Hyperglycaemia is therefore often reversible, and the most effective method of treatment of impaired insulin sensitivity is successful therapy of specific endocrinopathies. Insulin sensitisers, also with a good effect, are used. Most experiences to date can be attributed to metformin therapy. Attempts have been made at treatment with other agents that are also effective in reducing insulin resistance as incretins or glitazones. In the presented paper, the authors reviewed endocrine diseases in which there is a clinically significant change in insulin sensitivity. Moreover, methods of therapy of concomitant disturbed glucose metabolism were presented.

Abstract

Changes in sensitivity to insulin occur in the course of a number of endocrine disorders. Most of the hormones through their antagonistic action to insulin lead to increased hepatic glucose output and its decreased utilisation in peripheral tissues. Carbohydrate disorders observed in endocrine diseases result from the phenomenon of insulin resistance, and in some cases also a reduction in insulin secretion is present. Abnormalities of glucose metabolism are observed in acromegaly, but also in growth hormone deficiency, hypercortisolism in the course of Cushing’s syndrome, hyper- or hypothyroidism, primary hyperparathyroidism, aldosteronism, pheochromocytoma, congenital hypertrophy of the adrenal glands, polycystic ovaries syndrome, hypogonadism, or other hormonally active neuroendocrine tumours. They are of a secondary nature in relation to impaired hormonal balance. Hyperglycaemia is therefore often reversible, and the most effective method of treatment of impaired insulin sensitivity is successful therapy of specific endocrinopathies. Insulin sensitisers, also with a good effect, are used. Most experiences to date can be attributed to metformin therapy. Attempts have been made at treatment with other agents that are also effective in reducing insulin resistance as incretins or glitazones. In the presented paper, the authors reviewed endocrine diseases in which there is a clinically significant change in insulin sensitivity. Moreover, methods of therapy of concomitant disturbed glucose metabolism were presented.

Get Citation

Keywords

insulin resistance; endocrinopathies; diabetes mellitus

About this article
Title

Insulin resistance in endocrine disorders — treatment options

Journal

Endokrynologia Polska

Issue

Vol 68, No 3 (2017)

Article type

Review paper

Pages

334-351

Published online

2017-06-21

Page views

4852

Article views/downloads

5056

DOI

10.5603/EP.2017.0026

Pubmed

28660991

Bibliographic record

Endokrynol Pol 2017;68(3):334-351.

Keywords

insulin resistance
endocrinopathies
diabetes mellitus

Authors

Anita Rogowicz-Frontczak
Anna Majchrzak
Dorota Zozulińska-Ziółkiewicz

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl